Cepheid
Rebecca Truty is a Principal Bioinformatics Scientist at Cepheid since October 2022, following an extensive career at Invitae from February 2016 to July 2022, where roles included Bioinformatic Data Scientist focusing on polygenic risk score development, Head of Data Governance and Stewardship, and Lead of the Clinical Data Analysis team. Prior experience includes positions at Complete Genomics Inc. as a Senior Bioinformatics Analyst and Bioinformatics Analyst, and a Bioinformatics Fellow at The J. David Gladstone Institutes, UCSF. Rebecca earned a PhD in Nuclear Particle Physics from the University of Illinois Urbana-Champaign and a BS in Physics from Rensselaer Polytechnic Institute.
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.